FDA
-
-
-
-
-
-
-
New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis
-
-
-
-
-
-
-
John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening
-
-
-
-
-
-
-
Abbott receives FDA approval for Volt heart rhythm treatment system
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Abbott Labs (ABT)
-
-
-
-
-
-
-
Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology
-
-
-
-
-
-
-
RBC Capital: 'Opportunities Across MedTech Stocks'
-
-
-
-
-
-
-
Abbott Labs (ABT) PT Raised to $128 at Evercore ISI
-
327,805 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

